Miyoshi M, Uzui H, Shimizu T, et al. - Findings demonstrate an association of the mean of daily differences (MODD; calculated as a marker of day-to-day glycemic variability) with elevated N-terminal pro-brain natriuretic peptide (NT-proBNP) in acute coronary syndrome (ACS) patients.

• This study involved 25 patients with ACS to assess significance of day-to-day glycemic variability (GV) in them.

• Among study participants, 8 (32%) had diabetes, and a high continuous glucose monitoring-based MODD was seen in 17 patients (68%).

• There was no correlation between MODD and max creatine kinase, but a positive correlation was found between J-index, high blood glucose index, and NT-proBNP.